Skip to main content

This is a preprint.

It has not yet been peer reviewed by a journal.

The National Library of Medicine is running a pilot to include preprints that result from research funded by NIH in PMC and PubMed.

Research Square logoLink to Research Square
[Preprint]. 2023 Dec 6:rs.3.rs-3684698. [Version 1] doi: 10.21203/rs.3.rs-3684698/v1

A Fair Individualized Polysocial Risk Score for Identifying Increased Social Risk in Type 2 Diabetes

Yu Huang 1,a, Jingchuan Guo 2,a, William T Donahoo 3, Zhengkang Fan 1, Ying Lu 2, Wei-Han Chen 2, Huilin Tang 2, Lori Bilello 4, Aaron A Saguil 5, Eric Rosenberg 6, Elizabeth A Shenkman 1, Jiang Bian 1
PMCID: PMC10723535  PMID: 38106012

Abstract

Background:

Racial and ethnic minority groups and individuals facing social disadvantages, which often stem from their social determinants of health (SDoH), bear a disproportionate burden of type 2 diabetes (T2D) and its complications. It is crucial to implement effective social risk management strategies at the point of care.

Objective:

To develop an electronic health records (EHR)-based machine learning (ML) analytical pipeline to address unmet social needs associated with hospitalization risk in patients with T2D.

Methods:

We identified real-world patients with T2D from the EHR data from University of Florida (UF) Health Integrated Data Repository (IDR), incorporating both contextual SDoH (e.g., neighborhood deprivation) and individual-level SDoH (e.g., housing instability). The 2015–2020 data were used for training and validation and 2021–2022 data for independent testing. We developed a machine learning analytic pipeline, namely individualized polysocial risk score (iPsRS), to identify high social risk associated with hospitalizations in T2D patients, along with explainable AI (XAI) and fairness optimization.

Results:

The study cohort included 10,192 real-world patients with T2D, with a mean age of 59 years and 58% female. Of the cohort, 50% were non-Hispanic White, 39% were non-Hispanic Black, 6% were Hispanic, and 5% were other races/ethnicities. Our iPsRS, including both contextual and individual-level SDoH as input factors, achieved a C statistic of 0.72 in predicting 1-year hospitalization after fairness optimization across racial and ethnic groups. The iPsRS showed excellent utility for capturing individuals at high hospitalization risk because of SDoH, that is, the actual 1-year hospitalization rate in the top 5% of iPsRS was 28.1%, ~13 times as high as the bottom decile (2.2% for 1-year hospitalization rate).

Conclusion:

Our ML pipeline iPsRS can fairly and accurately screen for patients who have increased social risk leading to hospitalization in real word patients with T2D.

Keywords: Machine learning, Type 2 diabetes, Machine Learning, Prediction, Fairness

Introduction

Diabetes affects 529 million people worldwide and the number is projected to more than double in the next three decades, reaching 1.3 billion by 2050.1 Over 90% of diabetes cases are type 2 diabetes (T2D).2 Existing research has shown that social determinants of health (SDoH)—”the conditions in the environments where people are born, live, learn, work, play, worship, and age,3,4 such as education, income, and access to healthy food, play a critical role affecting a wide range of health outcomes, including the development and prognosis of T2D.57 Moreover, health disparities in T2D have been widely documented over the past decades.810 Racial and ethnic minority groups and individuals experiencing social disadvantages—often rooted in their SDoH—bear a disproportionate burden of T2D and its complications.1113 As such, diabetes is a public crisis that must be managed with sensitivity to patients’ unmet social needs to improve T2D outcomes and health equity.

The US health care system has begun embracing the need to address patients’ social needs, including screening for SDoH at the point of care. For example, the Centers for Medicare & Medicaid Services (CMS) have made proposals to require SDoH screening (e.g., housing stability, food insecurity, and access to transportation) in annual beneficiary health risk assessments. Despite this push, only 16%-24% of clinics and hospitals provide SDoH screening,15 and the actual utilization rate is very low.16 In a national network of community health centers, only 2% of patients were screened for SDoH, and most had only one SDoH documented.17 The reasons for the extremely low rate of SDoH screening are multiple. 18 First, existing screening tools are not automated, making them difficult to adapt to clinical workflows. 19,20 In addition, almost all tools were developed for universal screening but were not validated to predict specific conditions and outcomes such as diabetes.2123 Furthermore, screening for individual SDoH items at the point of care is not only inefficient, increasing the provider documentation burden, but also inadequate given the known complex interplay among the SDoH.2427 Figueroa et al. called for using a Polysocial Risk Score (PsRS) approach,28 yet existing PsRS studies include only individual-level SDoH examined in small cohort studies with limited generalizability.2931 It is essential to consider both contextual (e.g., neighborhood deprivation) and individual-level SDoH (e.g., if the individual has instable housing) in one model given their known interactions, especially for T2D, as shown by us and others.24,25,27,32

The increasing availability of real-world data (RWD)33,34—such as electronic health records (EHRs) and administrative claims —and the rapid advancement of artificial intelligence (AI), especially machine learning (ML) techniques to analyze RWD, provides an opportunity to develop novel personalized tools and generate real-world evidence for improving not only health outcomes but also health equity by addressing contextual-level and individual-level SDoH. However, key data and methodologic barriers exist. For example, RWD lack integration with contextual or individual-level SDoH data. Moreover, most studies that used ML models for clinical applications35 did not carefully consider the inherent biases in observational RWD, such as data bias where patients of low socioeconomic status may not be well-represented in EHRs due to their limited access to healthcare.36 A ML model naively trained on such RWD may deliver unfair outputs for racial-ethnic minority groups and socioeconomically disadvantaged individuals36, leading to increased health disparities and inequity. Moreover, the black box nature of ML models limits their adoption in clinical and health care applications; and explainable AI (XAI) techniques play a significant role in bridging the gap between complex ML models and human understanding.3739 Shapley Additive exPlanations (SHAP)40 is an increasingly used, simple tool for teasing out the contribution of individual factors to a predictive model, nevertheless, it has a limited ability to explain how factors collectively affect an outcome, given the complex interactions among factors, such as complex interplay among individual-level and contextual-level SDoH. Causal structure learning methods such as the classic PC algorithm41 can learn causal relationships among the factors in the format of a directed acyclic graph (DAG) from observational data, and reveal how these risk factors interact to influence outcomes, offering valuable insights into the underlying processes that drive the predictions.

Therefore, in this study, we aimed to develop an EHR-based ML pipeline, namely iPsRS, for determining if increased social risk can predict hospitalization in T2D, with in-depth consideration of model fairness and explainability. Specifically, we used RWD from the University of Florida Health (UF Health) EHRs and incorporated both individual-level and contextual-level SDoH for the iPsRS development, optimized its fairness across racial-ethnic groups, and identified key causal factors that can be targeted for interventions. With these algorithms, our long-term goal is to develop an EHR-based individualized social risk management platform that can integrate social risk management into clinical care, leading to a necessary paradigm shift in US healthcare delivery.

Methods

Study design and population

We conducted a retrospective cohort study using 2015–2021 EHR data from the UF Health Integrated Data Repository (IDR), an enterprise data warehouse integrating different patient information systems across the UF Health system. UF Health provides care to more than 1 million patients with over 3 million inpatient and outpatient visits each year with hospitals in Gainesville (Alachua County), Jacksonville (Duval County), and satellite clinics in other Florida counties. In the current study, we included patients who were (1) aged 18 and older, (2) had a T2D diagnosis, identified as having at least one inpatient or outpatient T2D diagnosis (using ICD-9 codes 250.×0 or 250. ×2, or ICD-10 code E11) and ≥ 1 glucose-lowering drug prescription in (a case finding algorithm previously validated in EHRs with a positive predictive value [PPV] >94%)42, and (3) had at least one encounter during both baseline period and the follow up year. The index date was defined as the first recorded T2D diagnosis in the UF Health IDR data. We traced back 3 years prior to the index date as the baseline period to collect predictor information and followed up for 1 year to collect outcome (i.e., hospitalization) information (Figure 1).

Figure 1.

Figure 1

Processing workflow of the University of Florida integrated data repository type 2 diabetes cohort and the patient timeline.

Study outcome

The study outcome was all-cause hospitalization within 1 year after the index date, identified using the first occurrence of an inpatient encounter during the follow-up year (Figure 1).

Covariates

Demographics and clinical characteristics

We collected patient demographic (age, sex, and race-ethnicity) and clinical information (comorbidities, co-medications, lab values and clinical observations) for the baseline period. Race-ethnicity included four categories, including non-Hispanic White (NHW), non-Hispanic Black (NHB), Hispanic, and 5% were other races/ethnicities. The zip codes of patient residences were collected during the baseline period for contextual-level SDoH linkage.

Individual-level SDoH via natural language processing

We employed a natural language processing 43,44 pipeline that was developed by our group 45 to extract individual-level SDoH information from clinical notes in the baseline period, including education level (i.e., college or above, high school or lower, and unknown), employment (i.e., employed, unemployed, retired or disabled, and unknown), financial constraints (i.e., has financial constraints and unknown), housing stability (i.e., homeless or shelter, stable housing, and unknown), food security (i.e., having food insecurity and unknown), marital status (i.e., single, married or has partner, widow or divorced, and unknown), smoking status (i.e., ever smokers, never, and unknown), alcohol use (i.e., yes, no, and unknown), and drug abuse (i.e., yes, no and unknown). We also obtained insurance information (i.e., private insurance, Medicare, Medicaid, No-pay, unknown and others) from structured data.

Contextual-level SDoH through spatiotemporal linkage with the external exposome data

To obtain the contextual-level SDoH, we extracted the built and social environment measures (n=114 variables) including information on food access, walkability, vacant land, neighborhood disadvantage, social capital, and crime and safety, from six well-validated sources with different spatiotemporal scales (Supplement Table S1) built upon our prior work.46,47 We spatiotemporally linked these measures to each patient based on their baseline residential address (i.e., patients’ 9-digit zip codes). Area-weighted averages were first calculated using a 250-mile buffer around the centroid of each 9-digit ZIP code. Time-weighted averages were then calculated, accounting for each individual’s residential address.

Development of ML pipeline for iPsRS

Figure 2 shows our overall analytics pipeline. First, we imputed missing data and then adopted balance processing techniques (Step 1. Preprocessing). After that, we trained a set of machine learning models by using grid search cross-validation to identify the best hyperparameters (Step 2. ML Modeling). Next, we evaluated the model prediction performance (Step 3. Performance Assessment) and utilized XAI and causal structure learning techniques to identify important causal SDoH contributing to the hospitalization outcome (Step 4. Explanation). Finally, we assessed the algorithmic fairness (Step 5. Fairness Assessment) and implemented a range of fairness mitigation algorithms to address the identified bias (Step 6. Fairness Mitigation).

Figure 2.

Figure 2

Data analytics pipeline.

Data preprocessing

We imputed missing values using the “unknown” label for categorical variables and the mean for continuous variables. Next, we proceeded to create dummy variables for the categorical variables and applied min-max normalization to the continuous variables.

Machine learning model development for iPsRS

We developed the iPsRS model for predicting hospitalizations in patients with T2D using three sets of input features: (1) individual-level SDoH only, (2) contextual-level SDoH only, and (3) individual- and contextual-level SDoH combined. Two classes of commonly used ML approaches, linear and tree-based models, were employed. For the linear models, we included a range of hyperparameters and penalty functions that can be utilized in constructing different models, including logistic regression48, lasso regression49, ridge regression50, and ElasticNet51. For the tree-based models, we selected Extreme Gradient Boosting (XGBoost), which is widely recognized as one of the best-in-class algorithms for decision-tree-based models and has shown remarkable prediction performance in a wide range of studies5257. Following ML best practices, the study data set was split into a modeling set that includes 2015 to 2020 data, and an independent testing set that covers data in 2021. In the modeling set, we further split the samples into training, validation, and testing sets with a ratio of 7:1:2. A five-fold cross-validation grid search was executed on the training set to optimize the model parameters, and early stopping was adopted and performed on the validation set to avoid overfitting. We employed random over-sampling (ROS), random under-sampling (RUS), and under-sampling by matching on Charlson Comorbidity Index (CCI) to address data imbalance before model training. The performance of each model was evaluated by area under the receiver operating characteristic curve (AUROC), F1 score, precision, recall, and specificity.

We acquired and assigned a hospitalization risk score using the iPsRS for each patient. We then divided the ranked risk scores into 11 risk groups (top 1–5th percentile, top 6–10th percentile, and following deciles), enabling us to examine the one-year hospitalization rate by risk group.58

Explainable AI and causal estimates

We first utilized SHAP40 – a commonly used XAI technique – to identify important SDoH features contributing to iPsRS predicting hospitalizations in T2D patients. Further, we used a causal structure learning model – the Mixed Graphical Models with PC-Stable (MGM-PC-Stable)41,5961 – to learn causal structures in directed acyclic graph (DAG) format explaining the potential causal relationships on how collectively the identified important SDoH features impact the hospitalization outcome in T2D patients.

Algorithmic fairness optimization

To assess the model fairness of iPsRS, we adopted seven popular algorithmic fairness metrics,36,62 including predictive parity, predictive equality (false positive rate [FPR] balance), equalized odds, conditional use accuracy equality, treatment equality, equality of opportunity (false negative rate [FNR] balance), and overall accuracy equality, detailed in Supplement S1. We primarily focused on balancing the FNR (those whom the model deemed low risk but indeed are at high risk) across racial-ethnic groups, particularly NHB and Hispanic vs. NHW, because hospitalization is an adverse health outcome. In terms of fairness, we wanted to ensure iPsRS did not have higher FNR in the disadvantaged groups (i.e., Hispanic and NHB groups) compared to the reference group (i.e., NHW). As there is no universally accepted cut-off value of fairness, we considered the parity measure of 0.80–1.25 as statistically fair and highlighted values outside this range.63

Decreasing the FNR of iPsRS means minimizing the false negative errors (i.e., those whom the model deemed low risk but indeed are at high risk) in the early detection of social risks that can lead to hospitalization. We then employed different bias mitigation techniques to optimize the algorithmic fairness of iPsRS, including pre-process (Disparate Impact Remover64 [DIR]), in-process (Adversarial Debiasing65 [ADB]), and post-process (Calibrated Equalized Odds Postprocessing66 [CEP]) approaches. We goal was to identify the final model with a good balance between prediction utility and fairness.

Python version 3.7 with the Python libraries Sciki-learn67, Imbalanced-learn68, and statsmodels69 were used for data processing, modeling, and result analysis tasks, AI Fairness 36070 for model fairness mitigation tasks, and Tetrad71 for causal structure learning.

Results

Descriptive statistics of the study cohort

Our final analysis comprised 10,192 eligible T2D patients in the cohort. Table 1 highlights the demographics, individual-level SDoH, and key contextual-level SDoH of the study population by race-ethnicity. The mean age was 58 (± 13) years, and 58% were women. Of the cohort, 50% were NHW, 39% were NHB, 6% were Hispanic, and 5% were other races/ethnicities; 41% were enrolled in Medicare, 15% in Medicaid, 31% in private insurance, and 5.7% were uninsured. Compared with NHW patients, NHB patients were younger (54.6 vs. 58.5 years, p < 0.01) and more likely to be covered by Medicaid (41% vs. 28%, p < 0.01). We identified that 20.8% of patients were single, 58.5% were married or in a relationship, and 20.1% were widowed or divorced. Crime rates were lower in neighborhoods predominantly NHW than neighborhoods with higher diversity.

Table 1.

Summary of demographic, individual-level SDoH, and key contextual-level SDoH of the study population.

Overall (n=10192) NHW (n=5133) NHB (n=4011) Hispanics (n=495) Others (n=553) p-value
Age 58.45 60.19 56.39 55.95 59.42 0.0049
Sex 0.0018
Male 4267 (41.9%) 2470 (48.1%) 1330 (33.2%) 212 (42.8%) 255 (46.1%)
Female 5925(58.1%) 2663 (51.9%) 2681 (66.8%) 283 (57.2%) 298 (53.9%)
Race/ethnicity <0.001
NHB 4011 (39.4%) 0 (0.0%) 4011 (100.0%) 0 (0.0%) 0 (0.0%)
NHW 5133 (50.4%) 5133 (100.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Hispanics 495 (4.9%) 0 (0.0%) 0 (0.0%) 495 (100.0%) 0 (0.0%)
Others 553 (5.4%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 553 (100.0%)
Insurance type <0.001
Medicare 4183 (41.0%) 2214 (43.1%) 1610 (40.1%) 170 (34.3%) 189 (34.2%)
Private 3169 (31.1%) 1663 (32.4%) 1144 (28.5%) 148 (29.9%) 214 (38.7%)
Medicaid 1511 (14.8%) 558 (10.9%) 804 (20.0%) 97 (19.6%) 52 (9.4%)
Nopay 579 (5.7%) 228 (4.4%) 285 (7.1%) 38 (7.7%) 28 (5.1%)
Unknown 537 (5.3%) 362 (7.1%) 84 (2.1%) 32 (6.5%) 59 (10.7%)
Others 213 (2.1%) 108 (2.1%) 84 (2.1%) 10 (2.0%) 11 (2.0%)
Marites status <0.001
Single 2116 (20.8%) 743 (14.5%) 1221 (30.4%) 80 (16.2%) 72 (13.0%)
Married or has partner 3570(35.0%) 2073 (40.4%) 1069 (26.7%) 179(36.2%) 249 (45.0%)
Widow or divorced 2050 (20.1%) 888 (17.3%) 1052 (26.2%) 65 (13.1%) 45 (8.1%)
Unknown 2456 (24.1%) 1429 (27.8%) 669 (16.7%) 171 (34.5%) 187 (33.8%)
Smoking status <0.001
Ever smokers 4096 (40.2%) 2331 (45.4%) 1473 (36.7%) 149 (30.1%) 143 (25.9%)
Never 5588 (54.8%) 2525 (49.2%) 2380 (59.3%) 321 (64.8%) 362 (65.5%)
Unknown 508(5.0%) 277(5.4%) 158 (3.9%) 25(5.1%) 48(8.7%)
Alcohol use <0.001
Yes 2631 (25.8%) 1381 (26.9%) 1012 (25.2%) 123 (24.8%) 115 (20.8%)
No 6650(65.2%) 3223(62.8%) 2737(68.2%) 325 (65.7%) 365 (66.0%)
Unknown 911 (9.0%) 529 (10.3%) 262 (6.5%) 47(9.5%) 73(13.2%)
Drug abuse <0.001
Yes 500 (4.9%) 225 (4.4%) 253 (6.3%) 16 (3.2%) 6 (1.1%)
No 8487 (83.3%) 4218 (82.2%) 3409 (85.0%) 417 (84.2%) 443 (80.1%)
Unknown 1205 (11.8%) 690 (13.4%) 349 (8.7%) 62(12.5%) 104 (18.8%)
Education level <0.001
College or above 978 (9.6%) 518 (10.1%) 376 (9.4%) 38 (7.7%) 46 (8.3%)
High school or lower 1110 (10.9%) 461 (9.0%) 563 (14.0%) 50 (10.1%) 36 (6.5%)
Unknown 8104 (79.5%) 4154 (80.9%) 3072 (76.6%) 407 (82.2%) 471 (85.2%)
Employment <0.001
Employed 3996 (39.2%) 2078 (40.5%) 1489 (37.1%) 207 (41.8%) 222(40.1%)
Unemployed 1439 (14.1%) 570 (11.1%) 760 (18.9%) 57 (11.5%) 52 (9.4%)
Retired or disabled 1948 (19.1%) 1017 (19.8%) 782 (19.5%) 68 (13.7%) 81 (14.6%)
Unknown 2809(27.6%) 1468 (28.6%) 980 (24.4%) 163 (32.9%) 198 (35.8%)
Housing stability <0.001
Homeless or shelter 80 (0.8%) 32 (0.6%) 44 (1.1%) 3 (0.6%) 1 (0.2%)
Stable housing 4215 (41.4%) 1971 (38.4%) 1933 (48.2%) 160 (32.3%) 151 (27.3%)
Unknown 5897 (57.9%) 3130 (61%) 2034 (50.7%) 332 (67.1%) 401 (72.5%)
Food security <0.001
Having food insecurity 7052(69.2%) 3416 (66.5%) 2982 (74.3%) 300 (60.6%) 354 (64.0%)
Unknown 3140 (30.8%) 1717 (33.5%) 1029 (25.7%) 195 (39.4%) 199 (36.0%)
Financial constraints 0.0092
Has financial constraints 5172 (50.7%) 2386 (46.5%) 2323 (57.9%) 216 (43.6%) 247 (44.7%)
Unknown 5020(49.3%) 2747 (53.5%) 1688 (42.1%) 279(56.4%) 306 (55.3%)
Percentage of low income and low access population at 1/2 mile for urban and 10 miles for rural 0.2625 (0.1965) 0.1944 (0.1733) 0.3528 (0.1946) 0.2579 (0.1740) 0.2442 (0.1685) 0.1708
Share of tract population that are seniors beyond 1/2 mile from supermarket −0.1661 (0.0949) −0.1635 (0.1035) −0.1669 (0.0831) −0.1734 (0.0837) −0.1779 (0.1000) < 0.001
Murder rate (per 100 population) 0.0075 (0.0043) 0.0064 (0.0040) 0.0089 (0.0041) 0.0076 (0.0041) 0.0074 (0.0044) < 0.001
Aggravated assault rate (per 100 population) 0.3867 (0.1365) 0.3767 (0.1704) 0.3980 (0.0753) 0.3994 (0.1489) 0.3858 (0.1060) < 0.001
Motor vehicle theft rate (per 100 population) 0.2348 (0.0882) 0.2042 (0.0921) 0.2718 (0.0684) 0.2420 (0.0785) 0.2440 (0.0794) < 0.001
Flag for low access tract at 1 mile for urban areas or 20 miles for rural areas counts < 0.001
Yes 4630 (45.4%) 2091 (40.7%) 2031 (50.6%) 253 (51.1.%) 306 (55.3%)
No 5562 (54.6%) 3042 (59.3%) 1980 (49.4%) 242 (48.9%) 247 (44.7%)

iPsRS prediction model of hospitalizations in T2D patients.

The best-performing models generated by XGBoost and ridge regression with three different sets of SDoH (individual-level SDoH only, contextual-level SDoH only and both combined) are shown in Figure 3. The models including individual-level SDoH only had reasonably good prediction utility (AUC 0.70–0.71) and adding contextual-level SDoH modestly improved the model performance (AUC 0.72), while contextual-level SDoH by themselves had suboptimal predicting performance (AUC 0.60–0.62).

Figure 3.

Figure 3

Model performance assessment of XGBoost and ridge regression.

In the independent testing set (the 2021 data), we calculated the one-year hospitalization rates by decile of the XGBoost-generated iPsRS, showing an excellent utility for capturing individuals at high hospitalization risk due to SDoH (i.e., one-year hospitalization risk in the top 5% of iPsRS was 28.1%, ~13 times higher than the bottom decile, Figure 4). In a multiple logistic regression model, after adjusting for patients’ demographics and clinical characteristics, iPsRS explained 33.8% of the risk of 1-year hospitalization, per decile increase of the iPsRS, the hospitalization risk increased by 22% (adjusted odds ratio=1.22, 95%CI 1.15–1.29).

Figure 4.

Figure 4

One-year hospitalization risk by iPsRS decile.

Explainable AI to identify important SDoH contributing to iPsRS predicting hospitalization in T2D patients

XGBoost (Figure 5) and Ridge model (Supplement S1) identified similar important features ranked by SHAP values. Housing stability status emerged as the most predictive feature in both models, followed by insurance type, share of tract population that are seniors beyond ½ mile from supermarket (food desert areas), and smoking status.

Figure 5.

Figure 5

Feature importance analysis with SHAP values. SHAP values from the original XGBoost. We removed the features with an “unknown” category.

Figure 6 displays our exploratory analysis with causal structure learning, applying MGM-PC-Stable method to build the causal DAGs of the key SDoH (i.e., 18 unique SDoH features by combining the top-15 features from both the XGBoost and ridge regression models), resulting in a causal graph with 19 nodes (i.e., 18 SDoH and the outcome) and 36 directed edges. We identified that the aggravated assault rate in the communities where patients live is closely, causally related to the hospitalization outcome (i.e., with having a direct causal connection to hospitalization in the DAG). Furthermore, the community’s rate of aggravated assault can be viewed as a common cause of both housing stability and hospitalization, forming a fork structure where housing stability and hospitalization are dependent and correlated but conditionally independent given the aggravated assault rate. This finding aligns with the insights derived from SHAP values obtained from both XGBoost and rigid leaner models, which suggests that an individual-level SDoH, housing stability, plays a significant role in T2D hospitalization, but this influence is conditioned by the contextual-level SDoH, specifically the rate of aggravated assault in our case.

Figure 6.

Figure 6

Causal graph generated by MGM-PC-Stable in the independent testing set. The yellow nodes present demographics, blue nodes stand for contextual-level SDoH and green nodes mean the individual-level SDoH, and the pink node indicates the outcome.

Fairness assessment and mitigation

Figure 7 displays the FNR curves across the racial-ethnic groups, where XGBoost (Figure 7-a) appears to be fairer than the linear model (Figure 7-b). The linear model shows a greater NHB and Hispanic groups than NHW (Table 2), suggesting the model is biased against NHB and Hispanic groups compared to NHW. The overall assessment of all seven-fairness metrics can be found in Supplement (Table S4).

Figure 7.

Figure 7

False negative rate (FNR) curve between different populations.

Table 2.

Statistical parity (equal opportunity) by different models on various feature sets.

Black & White Full SDoH Individual-level Contextual-level SDoH
Xgboost 1.03 0.98 1.24
Ridge regression 1.44 1.18 1.45
Hispanic & White Full SDoH Individual-level Contextual-level SDoH
Xgboost 1.22 1.00 1.63
Ridge regression 1.32 1.73 2.12

Figure 8 shows the improvement status of fairness of the ridge model after employing the different bias mitigation techniques. Overall, DIR demonstrated an excellent balancing prediction utility (AUCROC=0.71 vs. 0.72 of the original model) and fairness (FNR ratio decreased from xx to 1.07) between the NHB vs. NHW.

Figure 8.

Figure 8

Figure 8

NHB (protected group) vs. NHW (privileged group) and Hispanic vs. NHW, respectively. The ideally fair line is represented by the blue line, while the range of statistically fair is shown by the red dots. the ridge regression model initially fell outside the range of statistically fair but became fairer when we employed the fairness mitigation methods CEP, DIR, and ADB, resulting in equal opportunity regarding FNR raito.

(a) Mitigation results on the NHB vs NHW. CEP had the best fairness mitigation ability but led to a drastic decrease in model performance from 0.7220 to 0.5501, measured by AUROC, which is unacceptable. DIR and ADB resulted in an acceptable decrease in prediction performance, particularly with DIR’s AUROC decreasing from 0.7220 to 0.7100.

(b) Mitigation results on the Hispanic vs NHW. DIR and ADB struggled to handle the fairness mitigation. These methods turned to favoritism towards the protected group (Hispanic), resulting in biased predictions for the NHW group.

Discussion

In this project, we developed a fair, explainable ML pipeline, namely iPsRS, for identifying how social risk impacts hospitalizations in patients with T2D. We used UF Health EHR data, including 10,192 real-world patients with T2D, and incorporated both individual-level and contextual-level SDoH. Our results demonstrated that iPSRS is a promising tool for accurately and fairly detecting patients with a higher social risk for poor outcomes, providing explainable information on focal targets for future interventions.

Addressing patients’ unmet social needs in health care settings is a complex task due to 1) the insufficient SDoH records in EHRs (e.g., lack of use of Z codes for SDoH-associated diagnosis,72 and extremely low utilization of existing SDoH screening surveys embedded in EHRs17), 2) the concerns about the extra burden on providers11,73,74 and potential harms on patients20,22,23,75, 3) the potential data bias associated with SDoH that exists within subpopulations (e.g., racial and ethnic minority groups12), and 4) the observational natural of real-world EHR data (e.g., confounding and selection bias).76 Our EHR-based iPsRS pipeline was carefully designed to overcome the abovementioned limitations. For example, our iPsRS considers both contextual SDoH (by spatiotemporally linking patients’ EHR with the external exposome data using residential histories32) and individual-level SDoH (via extracting from clinical notes using our established NLP pipeline45). Our analyses suggested that adding contextual SDoH improved the prediction of hospitalization risk in T2D compared to the individual-level SDoH-only prediction. In addition, we employed ML approaches in EHR data to develop the iPsRS that can be embedded in EHR systems and automated for applications to minimize the extra burden of health care providers. Moreover, our model is designed to generate an initial iPsRS based on historical EHR data at the beginning of a medical encounter to guide targeted, in-person conversations between the patient and provider to collect additional SDoH information and update the iPsRS as needed, which has been carefully considered for its integration into existing clinical workflow to avoid potential harms to patients imposed by survey-type SDoH screenings and to promote patient-provider shared decision making on addressing patients’ unmet social needs. 20,22,23,75

With applications of multiple XAI and causal learning techniques. e.g., SHAP 40 values to identify key predictors and causal structure learning 41,5961 to identify causal pathways, our iPsRS is able to generate interpretable outputs and has shown its ability to identify potential focal targets for intervention and policy programs to address patients’ unmet social needs essential to their health outcomes. Specifically, our SHAP value and causal structure learning model consistently identified housing instability as one of the key, modifiable factors contributing to the increased risk of hospitalization in patients with T2D. These results demonstrate a real-world use case of our iPsRS that can be used to identify SDoH-based interventions tailored to individual patients’ needs.

Another strength of our study is that we assessed the algorithmic fairness of the iPsRS and mitigated the identified bias to ensure equitable prediction across racial/ethnic groups and other sensitive attributes (i.e., sex). After fairness assessment, we identified that the ridge regression model is biased against racial and ethnic minority groups. Its prediction produced a higher FNR for both NHB and Hispanic groups compared to the NHW group, that is, NHB and Hispanic individuals who were truly at high risk of hospitalizations are more likely to be misclassified as low risk, thus more likely to miss the subsequent intervention opportunities. We applied pre-processing (DIR), in-processing (ADB), and post-processing (CEP) methods to comprehensively evaluate the effect approach to optimize iPsRS fairness. In our final model, after applying the DIR approach for bias mitigation, the iPsRS achieved an excellent prediction utility-fairness balance. That is, the AUROC was comparable (0.71 vs. 0.72 of the original model), and equal opportunity of FNR between the NHB and NHW much improved (e.g., FNR ratio decreased from 1.44 to 1.07).

We consider our PsRS pipeline has important clinical implications. Our model showed an excellent utility for capturing individuals at high hospitalization risk due to SDoH (i.e., one-year hospitalization risk in the top 5% of iPsRS was 28.1%, approximately13 times higher than the bottom decile). Our iPsRS explained 33.8% of the risk of 1-year hospitalization after adjusting for patients’ demographics and clinical characteristics, suggesting that 33.8% of increased hospitalization risk in T2D can be attributed to patients’ unmet social needs, and factors outside patients’ clinical profile. The current US health care system faces critical barriers to addressing patients’ social risks essential to health.77 Existing SDoH screening tools and interventions have limited efficiency and effectiveness for improving health outcomes and health equity as most of them are not tailored to address specific conditions and outcomes (e.g., T2D), and there is insufficient evidence on effective SDoH interventions, leading to a dearth of actionable knowledge (e.g., which SDoH should be addressed and prioritized among which individuals and their effects on T2D outcomes and disparities). RWD and AI/ML offer the opportunity to develop innovative, digital approaches to integrate social risk management into T2D care and promote a learning health community. In this project, we addressed critical methodologic barriers, including shortcomings in existing RWD infrastructure for studying SDoH, and the need for an iPsRS approach for accurate, efficient, fair, and explainable social risk screening. With these algorithms, our next step is to co-design with diverse stakeholders an EHR-based individualized social risk management platform that can integrate social risk management into clinical care, leading to a necessary paradigm shift in US healthcare delivery. This tool also provides a method of consolidating multiple components of assessing SDoH into a single, comparable score which would likely increase the likelihood of utilization by clinicians at the point of care.

Our study is subject to several limitations. First, the analysis conducted in our study was based on a cohort of patients with T2D in the state of Florida. This limited geographical scope may impact the generalizability of our findings to populations from other regions. However, our real-world T2D patients from Florida were highly diverse (e.g., 39% of Black individuals) with a mixture of rural and urban populations, reflecting the demographic changes occurring across the US. Nevertheless, future research should aim to broaden the generalizability of our iPsRS through federated learning and data from different geographic regions.78 Second, to ensure the automated feature, we only integrated individual-level SDoH variables that were already included in the NLP extracting SDoH pipeline (SODA45) and thus some of the important diabetes-related factors were missing, such as stress. We will continue developing NLP pipelines for expanding the list of SDoH extraction and updating our iPsRS model. Third, we based on ML practices to select and tune the proposed iPsRS, hence the searching space of models and hyperparameters is constrained. We plan to utilize AutoML pipelines to enhance model accuracy and reliability, while simultaneously minimizing the time and resources required to develop the next-generation model.

In this project, we developed an ML-based analytic pipeline, namely iPsRS, for identifying the increased social risk of hospitalizations in real-world patients with T2D. Our iPsRS has been shown as a promising tool to accurately and fairly identify patients’ unmet social needs essential to adverse health outcomes. The iPsRS have the great potential to be integrated into EHR systems and clinical workflow and eventually augment current screening programs for SDoH to provide physicians with an efficient and effective tool to address SDoH in clinical settings.

Funding:

NIH/NIDDK (R01DK133465)

Footnotes

Competing Interests: The authors declare no conflict of interest relevant to the study.

Disclosures/Conflict of Interests

Dr. Guo received research funding from PhRMA foundation and consulting fee from Pfzier, all outside the current work.

Institutional Review Board Statement: Exempt approved by University of Florida IRB (IRB202201196)

Code Availability Statement: The codes presented in this study are available on request from the corresponding author.

Data Availability Statement:

The data presented in this study are available on request from the corresponding author. The data are not publicly available due to privacy restrictions.

Reference

  • 1.Ong KL, Stafford LK, McLaughlin SA, et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203–234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.CDC. Type 2 Diabetes. Centers for Disease Control and Prevention. Published 2022. Accessed February 14, 2023. https://www.cdc.gov/diabetes/basics/type2.html [Google Scholar]
  • 3.Social Determinants of Health. Accessed March 9, 2023. https://health.gov/healthypeople/priority-areas/social-determinants-health
  • 4.Marmot M, Friel S, Bell R, Houweling TAJ, Taylor S, Commission on Social Determinants of Health. Closing the gap in a generation: health equity through action on the social determinants of health. Lancet. 2008;372(9650):1661–1669. [DOI] [PubMed] [Google Scholar]
  • 5.Bryant T, Daiski I, Lines E, Others. Type 2 diabetes: poverty, priorities and policy: the social determinants of the incidence and management of Type 2 diabetes [monograph on the Internet]. Toronto, Ontario, Canada: York University School of Health Policy and Management; 2010. Mar 16 [cited 2011 Sep 20]. [Google Scholar]
  • 6.Clark ML, Utz SW. Social determinants of type 2 diabetes and health in the United States. World J Diabetes. 2014;5(3):296–304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Hill J, Nielsen M, Fox MH. Understanding the social factors that contribute to diabetes: a means to informing health care and social policies for the chronically ill. Perm J. 2013;17(2):67–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Spanakis EK, Golden SH. Race/ethnic difference in diabetes and diabetic complications. Curr Diab Rep. 2013;13(6):814–823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kyrou I, Tsigos C, Mavrogianni C, et al. Sociodemographic and lifestyle-related risk factors for identifying vulnerable groups for type 2 diabetes: a narrative review with emphasis on data from Europe. BMC Endocr Disord. 2020;20(Suppl 1):134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Kelly SJ, Ismail M. Stress and Type 2 Diabetes: A Review of How Stress Contributes to the Development of Type 2 Diabetes. Annu Rev Public Health. 2015;36(1):441–462. [DOI] [PubMed] [Google Scholar]
  • 11.Hill-Briggs F, Adler NE, Berkowitz SA, et al. Social Determinants of Health and Diabetes: A Scientific Review. Diabetes Care. 2020;44(1):258–279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Hill-Briggs F, Ephraim PL, Vrany EA, et al. Social Determinants of Health, Race, and Diabetes Population Health Improvement: Black/African Americans as a Population Exemplar. Curr Diab Rep. 2022;22(3):117–128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ogunwole SM, Golden SH. Social Determinants of Health and Structural Inequities—Root Causes of Diabetes Disparities. Diabetes Care. 2020;44(1):11–13. [DOI] [PubMed] [Google Scholar]
  • 14.Landauer R, McCrady E, Garfield K. Medicare’s Current Strategy For Health-Related Social Needs Is Necessary But Not Sufficient. Health Affairs Forefront. doi: 10.1377/forefront.20220901.523201 [DOI] [Google Scholar]
  • 15.Fraze TK, Brewster AL, Lewis VA, Beidler LB, Murray GF, Colla CH. Prevalence of screening for food insecurity, housing instability, utility needs, transportation needs, and interpersonal violence by US physician practices and hospitals. JAMA Netw Open. 2019;2(9):e1911514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.LaForge K, Gold R, Cottrell E, et al. How 6 organizations developed tools and processes for social determinants of health screening in primary care: An overview. J Ambul Care Manage. 2018;41(1):2–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Cottrell EK, Dambrun K, Cowburn S, et al. Variation in electronic health record documentation of social determinants of health across a national network of community health centers. Am J Prev Med. 2019;57(6 Suppl 1):S65–S73. [DOI] [PubMed] [Google Scholar]
  • 18.Henrikson NB, Blasi PR, Dorsey CN, et al. Psychometric and pragmatic properties of social risk screening tools: A systematic review. Am J Prev Med. 2019;57(6 Suppl 1):S13–S24. [DOI] [PubMed] [Google Scholar]
  • 19.Billioux A, Centers for Medicare and Medicaid Services, Verlander K, et al. Standardized screening for health-related social needs in clinical settings: The accountable health communities screening tool. NAM perspect. 2017;7(5). doi: 10.31478/201705b [DOI] [Google Scholar]
  • 20.Tong ST, Liaw WR, Kashiri PL, et al. Clinician experiences with screening for social needs in primary care. J Am Board Fam Med. 2018;31(3):351–363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Cantor MN, Thorpe L. Integrating data on social determinants of health into electronic health records. Health Aff (Millwood). 2018;37(4):585–590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Eder M, Henninger M, Durbin S, et al. Screening and interventions for social risk factors: Technical brief to support the US Preventive Services Task Force. JAMA. 2021;326(14):1416–1428. [DOI] [PubMed] [Google Scholar]
  • 23.Theis RP, Blackburn K, Lipori G, et al. Implementation context for addressing social needs in a learning health system: a qualitative study. J Clin Transl Sci. 2021;5(1):e201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Guo J, Hu H, Zheng Y, et al. Interplay of Contextual- And Personal-level Social Determinants Of Health And Real-world Adoption Of Novel Treatments For Improving Cardiovascular Outcomes In Type 2 Diabetes. Circulation. 2022;145(Suppl_1):A003–A003. [Google Scholar]
  • 25.Mayne SL, Hicken MT, Merkin SS, et al. Neighbourhood racial/ethnic residential segregation and cardiometabolic risk: the multiethnic study of atherosclerosis. J Epidemiol Community Health. 2019;73(1):26–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Singh GK. Area deprivation and widening inequalities in US mortality, 1969–1998. Am J Public Health. 2003;93(7):1137–1143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Bilal U, Auchincloss AH, Diez-Roux AV. Neighborhood environments and diabetes risk and control. Curr Diab Rep. 2018;18(9):62. [DOI] [PubMed] [Google Scholar]
  • 28.Figueroa JF, Frakt AB, Jha AK. Addressing Social Determinants of Health: Time for a Polysocial Risk Score. JAMA. 2020;323(16):1553–1554. [DOI] [PubMed] [Google Scholar]
  • 29.Ping Y, Oddén MC, Stawski RS, Abdel Magid HS, Wu C. Creation and validation of a polysocial score for mortality among community-dwelling older adults in the USA: the health and retirement study. Age Ageing. Published online August 28, 2021. doi: 10.1093/ageing/afab174 [DOI] [PubMed] [Google Scholar]
  • 30.Javed Z, Valero-Elizondo J, Dudum R, et al. Development and validation of a polysocial risk score for atherosclerotic cardiovascular disease. Am J Prev Cardiol. 2021;8:100251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.He Y, Lakhani CM, Rasooly D, Manrai AK, Tzoulaki I, Patel CJ. Comparisons of polyexposure, polygenic, and clinical risk scores in risk prediction of type 2 diabetes. Diabetes Care. 2021;44(4):935–943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Li Y, Hu H, Zheng Y, et al. Impact of contextual-level social determinants of health on newer antidiabetic drug adoption in patients with type 2 diabetes. Int J Environ Res Public Health. 2023;20(5). doi: 10.3390/ijerph20054036 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Concato J, Corrigan-Curay J. Real-world evidence - where are we now? N Engl J Med. 2022;386(18):1680–1682. [DOI] [PubMed] [Google Scholar]
  • 34.Sherman RE, Anderson SA, Dal Pan GJ, et al. Real-world evidence - what is it and what can it tell us? N Engl J Med. 2016;375(23):2293–2297. [DOI] [PubMed] [Google Scholar]
  • 35.Huang J, Galal G, Etemadi M, Vaidyanathan M. Evaluation and Mitigation of Racial Bias in Clinical Machine Learning Models: Scoping Review. JMIR Med Inform. 2022;10(5):e36388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Xu J, Xiao Y, Wang WH, et al. Algorithmic fairness in computational medicine. eBioMedicine. 2022;84. doi: 10.1016/j.ebiom.2022.104250 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Saraswat D, Bhattacharya P, Verma A, et al. Explainable AI for Healthcare 5.0: Opportunities and Challenges. IEEE Access. 2022;10:84486–84517. [Google Scholar]
  • 38.Loh HW, Ooi CP, Seoni S, Barua PD, Molinari F, Acharya UR. Application of explainable artificial intelligence for healthcare: A systematic review of the last decade (2011–2022). Comput Methods Programs Biomed. 2022;226:107161. [DOI] [PubMed] [Google Scholar]
  • 39.Payrovnaziri SN, Chen Z, Rengifo-Moreno P, et al. Explainable artificial intelligence models using real-world electronic health record data: a systematic scoping review. J Am Med Inform Assoc. 2020;27(7):1173–1185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Lundberg S, Lee SI. A unified approach to interpreting model predictions. arXiv [csAI]. Published online May 22, 2017. Accessed January 15, 2023. https://proceedings.neurips.cc/paper/2017/hash/8a20a8621978632d76c43dfd28b67767-Abstract.html [Google Scholar]
  • 41.Spirtes P, Glymour C, Scheines R. Causation, Prediction, and Search. Springer; New York [Google Scholar]
  • 42.Wiese AD, Roumie CL, Buse JB, et al. Performance of a computable phenotype for identification of patients with diabetes within PCORnet: The Patient-Centered Clinical Research Network. Pharmacoepidemiol Drug Saf. 2019;28(5):632–639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Yu Z, Yang X, Guo Y, Bian J, Wu Y. Assessing the Documentation of Social Determinants of Health for Lung Cancer Patients in Clinical Narratives. Front Public Health. 2022;10:778463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Yu Z, Yang X, Dang C, et al. A Study of Social and Behavioral Determinants of Health in Lung Cancer Patients Using Transformers-based Natural Language Processing Models. AMIA Annu Symp Proc. 2021;2021:1225–1233. [PMC free article] [PubMed] [Google Scholar]
  • 45.Yu Z, Yang X, Dang C, et al. SODA: A Natural Language Processing Package to Extract Social Determinants of Health for Cancer Studies. arXiv [csCL]. Published online December 6, 2022. http://arxiv.org/abs/2212.03000 [Google Scholar]
  • 46.Zhang H, Hu H, Diller M, et al. Semantic standards of external exposome data. Environ Res. 2021;197:111185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Hu H, Zheng Y, Wen X, et al. An external exposome-wide association study of COVID-19 mortality in the United States. Sci Total Environ. 2021;768:144832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Tolles J, Meurer WJ. Logistic Regression: Relating Patient Characteristics to Outcomes. JAMA. 2016;316(5):533–534. [DOI] [PubMed] [Google Scholar]
  • 49.Tibshirani R. Regression Shrinkage and Selection via the Lasso. J R Stat Soc Series B Stat Methodol. 1996;58(1):267–288. [Google Scholar]
  • 50.Hoerl AE, Kennard RW. Ridge Regression: Biased Estimation for Nonorthogonal Problems. Technometrics. 1970;12(1):55–67. [Google Scholar]
  • 51.Zou H, Hastie T. Regularization and Variable Selection via the Elastic Net. J R Stat Soc Series B Stat Methodol. 2005;67(2):301–320. [Google Scholar]
  • 52.Shin J, Lee J, Ko T, Lee K, Choi Y, Kim HS. Improving Machine Learning Diabetes Prediction Models for the Utmost Clinical Effectiveness. J Pers Med. 2022;12(11). doi: 10.3390/jpm12111899 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Zhao Y, Li X, Li S, et al. Using Machine Learning Techniques to Develop Risk Prediction Models for the Risk of Incident Diabetic Retinopathy Among Patients With Type 2 Diabetes Mellitus: A Cohort Study. Front Endocrinol. 2022;13:876559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Deberneh HM, Kim I. Prediction of Type 2 Diabetes Based on Machine Learning Algorithm. Int J Environ Res Public Health. 2021;18(6). doi: 10.3390/ijerph18063317 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Li Y, Wang H, Luo Y. Improving Fairness in the Prediction of Heart Failure Length of Stay and Mortality by Integrating Social Determinants of Health. Circ Heart Fail. 2022;15(11):e009473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Yang H, Li J, Liu S, Yang X, Liu J. Predicting Risk of Hypoglycemia in Patients With Type 2 Diabetes by Electronic Health Record-Based Machine Learning: Development and Validation. JMIR Med Inform. 2022;10(6):e36958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Wang L, Wang X, Chen A, Jin X, Che H. Prediction of Type 2 Diabetes Risk and Its Effect Evaluation Based on the XGBoost Model. Healthcare (Basel). 2020;8(3). doi: 10.3390/healthcare8030247 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Lockhart RS. Introduction to Statistics and Data Analysis: For the Behavioral Sciences. Macmillan; 1998. [Google Scholar]
  • 59.Lee JD, Hastie TJ. Learning the Structure of Mixed Graphical Models. J Comput Graph Stat. 2015;24(1):230–253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Raghu VK, Poon A, Benos PV. Evaluation of Causal Structure Learning Methods on Mixed Data Types. Proc Mach Learn Res. 2018;92:48–65. [PMC free article] [PubMed] [Google Scholar]
  • 61.Colombo D, Maathuis MH. Order-independent constraint-based causal structure learning. J Mach Learn Res. Published online 2014. https://www.jmlr.org/papers/volume15/colombo14a/colombo14a.pdf
  • 62.Castelnovo A, Crupi R, Greco G, Regoli D, Penco IG, Cosentini AC. A clarification of the nuances in the fairness metrics landscape. Sci Rep. 2022;12(1):1–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Chouldechova A. Fair prediction with disparate impact: A study of bias in recidivism prediction instruments. Big Data. 2017;5(2):153–163. [DOI] [PubMed] [Google Scholar]
  • 64.Feldman M, Friedler SA, Moeller J, Scheidegger C, Venkatasubramanian S. Certifying and Removing Disparate Impact. In: Proceedings of the 21th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. KDD ‘15. Association for Computing Machinery; 2015:259–268. [Google Scholar]
  • 65.Zhang BH, Lemoine B, Mitchell M. Mitigating Unwanted Biases with Adversarial Learning. In: Proceedings of the 2018 AAAI/ACM Conference on AI, Ethics, and Society. AIES ‘18. Association for Computing Machinery; 2018:335–340. [Google Scholar]
  • 66.Pleiss G, Raghavan M, Wu F, Kleinberg J, Weinberger KQ. On Fairness and Calibration. In: Guyon I, Luxburg UV, Bengio S, et al. , eds. Advances in Neural Information Processing Systems. Vol 30. Curran Associates, Inc.; 2017. https://proceedings.neurips.cc/paper/2017/file/b8b9c74ac526fffbeb2d39ab038d1cd7-Paper.pdf [Google Scholar]
  • 67.Pedregosa F, Varoquaux G, Gramfort A, et al. Scikit-learn: Machine Learning in Python. J Mach Learn Res. 2011;12(85):2825–2830. [Google Scholar]
  • 68.Lemaitre G, Nogueira F, Aridas CK. Imbalanced-learn: A python toolbox to tackle the curse of imbalanced datasets in machine learning. arXiv [csLG]. Published online September 21, 2016. Accessed February 8, 2023. https://www.jmlr.org/papers/volume18/16-365/16-365.pdf
  • 69.Seabold S, Perktold J. Statsmodels: Econometric and statistical modeling with python. In: Proceedings of the 9th Python in Science Conference. SciPy; 2010. doi: 10.25080/majora-92bf1922-011 [DOI] [Google Scholar]
  • 70.Bellamy RKE, Dey K, Hind M, et al. AI Fairness 360: An extensible toolkit for detecting and mitigating algorithmic bias. IBM J Res Dev. 2019;63(4/5):4:1–4:15. [Google Scholar]
  • 71.Ramsey JD, Zhang K, Glymour M, et al. TETRAD - A TOOLBOX FOR C AUSAL D ISCOVERY. Accessed August 5, 2023. https://www.atmos.colostate.edu/~iebert/PAPERS/CI2018_paper_35.pdf
  • 72.Guo Y, Chen Z, Xu K, et al. International Classification of Diseases, Tenth Revision, Clinical Modification social determinants of health codes are poorly used in electronic health records. Medicine (Baltimore). 2020;99(52):e23818. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Weinstein E, Galindo RJ, Fried M, Rucker L, Davis NJ. Impact of a focused nutrition educational intervention coupled with improved access to fresh produce on purchasing behavior and consumption of fruits and vegetables in overweight patients with diabetes mellitus. Diabetes Educ. 2014;40(1):100–106. [DOI] [PubMed] [Google Scholar]
  • 74.Egede LE, Walker RJ, Linde S, et al. Nonmedical Interventions For Type 2 Diabetes: Evidence, Actionable Strategies, And Policy Opportunities. Health Aff. 2022;41(7):963–970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Schleifer D. It’s about Trust: Low-Income Parents’ Perspectives on How Pediatricians Can Screen for Social Determinants of Health. Health Serv Res. Published online 2020. 10.1111/1475-6773.13524?casa_token=2BUO6MQv4lAAAAAA:83viGh_JmS7XGAFeG8b08XBR0JlRW9PoRs6jVXuqSNGfnrOxuZ9Ys1TM4t_8vf-3p7H_TQVravdQybvd [DOI] [Google Scholar]
  • 76.Hammer GP, du Prel JB, Blettner M. Avoiding bias in observational studies: part 8 in a series of articles on evaluation of scientific publications. Dtsch Arztebl Int. 2009;106(41):664–668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.The Physicians Foundation 2022. Physician Survey: Part 1 Examining How the Social Drivers of Health Affect the Nation’s Physicians and their Patients. The Physicians Foundation. Published April 5, 2022. Accessed June 12, 2022. https://physiciansfoundation.org/physician-and-patient-surveys/the-physicians-foundation-2022-physician-survey-part-1/ [Google Scholar]
  • 78.Xu J, Glicksberg BS, Su C, Walker P, Bian J, Wang F. Federated Learning for Healthcare Informatics. Int J Healthc Inf Syst Inform. 2021;5(1):1–19. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not publicly available due to privacy restrictions.


Articles from Research Square are provided here courtesy of American Journal Experts

RESOURCES